Strategic Regulatory Partner for Success in Hong Kong

With a dual healthcare system (Public & Private) and a thriving pharmaceutical manufacturing sector, Hong Kong presents significant growth opportunities for foreign medicinal and medical device manufacturers aiming to enter the region. While the Department of Health (DoH) oversees drug registration and the regulation of imports/exports, the Medical Device Control Office (MDCO) governs medical device regulatory requirements. However, strict regulatory protocols and extended approval timelines (ranging from 18–24 months for drugs) can pose challenges to manufacturers aiming for quicker time-to-market.

As a specialized global Regulatory partner, Pharma Wizard supports organizations with deep expertise in the Hong Kong Regulatory system. Our dedicated Regulatory teams provide end-to-end support for preparing and reviewing registration documents, managing submissions, and securing approvals from health authorities—within compliant timeframes. To streamline your market access, Pharma Wizard also offers expert advice on Regulatory consultation and submission strategies.